Boyle James M 4
4 · Medline Inc. · Filed Jun 17, 2026
Research Summary
AI-generated summary of this filing
Medline CEO James Boyle Withholds 2,370 Shares for Taxes
What Happened
James M. Boyle, CEO of Medline (MDLN), had 2,370 shares withheld on June 15, 2026 to cover tax liability tied to the vesting of restricted stock units. The shares were recorded at $36.61 each, representing $86,766 in value. This was a tax-withholding disposition (not an open-market sale).
Key Details
- Transaction date: 2026-06-15; Filing date: 2026-06-17 (timely Form 4 filing).
- Details: 2,370 shares withheld at $36.61 per share = $86,766.
- Transaction code: F (shares withheld to satisfy tax liability). Footnote F1: confirms withholding was to satisfy taxes on RSU vesting.
- Shares owned after transaction: not provided in the excerpt of the filing.
Context
Tax-withholdings on vested RSUs are routine and do not indicate an active sale or change in insider sentiment — they simply cover the officer’s tax obligation at vesting. This is different from an open-market sale (S) or a purchase (P), which are more directly informative about an insider’s market view.
Insider Transaction Report
Form 4
Medline Inc.MDLN
Boyle James M
DirectorChief Executive Officer
Transactions
- Tax Payment
Class A Common Stock
[F1]2026-06-15$36.61/sh−2,370$86,766→ 29,369 total
Footnotes (1)
- [F1]Reflects shares withheld to satisfy the Reporting Person's tax liability in connection with the vesting of restricted stock units.
Signature
/s/ Nicole Fritz, Attorney-in-Fact|2026-06-17